This study aimed to compare perioperative outcomes, complication rates, and incidental thyroid cancer prevalence in patients undergoing surgery for benign multinodular goiter versus toxic multinodular goiter. A retrospective analysis of 202 patients (110 MNG, 92 TMNG) with Bethesda II cytology was conducted. Inclusion criteria comprised adults with multinodular goiter or toxic multinodular goiter, while exclusion criteria included preoperative malignancy suspicion, Graves’ disease, or incomplete data. All surgeries were performed by high-volume endocrine surgeons using standardized techniques, including intraoperative nerve monitoring and ultrasonic dissection. Data on demographics, ultrasonographic features, surgical complications (hypocalcemia, recurrent laryngeal nerve injury, hemorrhage), and final histopathological diagnosis were analyzed. Of the 202 cases, 19.8% were male and 80.2% were female (mean age 49.8±12.2 years). TMNG patients presented with significantly smaller mean nodule diameters (26.1 mm vs. 38.9 mm, p=0.001) and a higher frequency of hypoechogenicity (38% vs. 26.4%, p=0.03) compared to MNG. No significant differences were found in gender, age (p=0.059), or postoperative calcium levels. Incidental malignancy rates were 16.3% in MNG and 8.6% in TMNG (p=0.10). While postoperative bleeding did not reach formal statistical significance (5.4% in TMNG vs. 0.9% in MNG, p=0.09), a clinically notable six-fold increase in the odds ratio was observed (OR: 6.26; 95% CI: 0.72–54.55). Surgical management of TMNG is safe when performed by experienced surgeons; however, the elevated odds ratio for bleeding warrants heightened perioperative vigilance. The incidental cancer risk does not significantly differ between groups, though the lower prevalence in TMNG may be influenced by smaller nodule size enhancing preoperative biopsy accuracy.